Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dantrolene for Darier disease
2020-004281-19Phase 2Active
- Sponsor
- Karolinska University Hospital
- Start
- Oct 2020
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of dantrolene in Darier disease, sponsored by Karolinska University Hospital. Started Oct 2020; status: active.
02
Drugs
dantrolene
03
Conditions
Darier disease
Beyond the preview
Go deeper on 2020-004281-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004281-19.